Shuttle Pharmaceuticals Company Top Insiders

Shuttle Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (3.233) % which means that it has lost $3.233 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (271.7618) %, meaning that it created substantial loss on money invested by shareholders. Shuttle Pharmaceuticals' management efficiency ratios could be used to measure how well Shuttle Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The Shuttle Pharmaceuticals' current Return On Tangible Assets is estimated to increase to -3,986. The Shuttle Pharmaceuticals' current Return On Capital Employed is estimated to increase to -8,646. As of now, Shuttle Pharmaceuticals' Non Currrent Assets Other are increasing as compared to previous years. The Shuttle Pharmaceuticals' current Common Stock Shares Outstanding is estimated to increase to about 10.4 M, while Net Loss is forecasted to increase to (2.7 M). Shuttle Pharmaceuticals has 3.27 % of its outstanding shares held by insiders and 12.51 % owned by institutional holders. Some institutional investors establish a significant position in stocks such as Shuttle Pharmaceuticals in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Shuttle Pharmaceuticals, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Shuttle Pharmaceuticals Workforce Comparison

Shuttle Pharmaceuticals Insider Trading

Shuttle Pharmaceuticals Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Shuttle Pharmaceuticals often depends on how effective the management is. Shuttle Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Shuttle management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Shuttle management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.